Drooid Logo
Back to story perspectives

Full Breakdown

Senator Josh Hawley Presses House to Block Federal Funding for Gender-Affirming Care for Minors

4/28/2026, 2:30:49 AM

Legislative Push to Bar Taxpayer Funding for Trans-Treatment

Senator Josh Hawley (R-MO) sent a letter to House Speaker Mike Johnson urging the Republican-controlled House to amend the fiscal year-2025 budget resolution with language that would prohibit any federal dollars from being used for gender-affirming medical treatment for minors. Hawley argues that, without such a provision, “billions of Federal dollars will go to Planned Parenthood and other medical ‘providers’ for hormones, puberty blockers, and irreversible treatments for minor children.” He frames the issue as a fiscal imperative, citing the impending expiration of a federal bar on taxpayer payments to “trans-treatment and abortion providers” on July 4.

Background: Prior Congressional Actions and Federal Guidance

In December 2023, the House passed a bill that would criminalize doctors and parents who provide gender-affirming care to minors—the first chamber-wide vote for a national ban. The Senate, however, rejected a comparable prohibition, and attempts to attach the measure to a budget resolution failed. Concurrently, federal courts have blocked guidance issued by Health and Human Services Secretary Robert F. Kennedy that sought to restrict care for transgender youth.

Key Actors

  • Sen. Josh Hawley (R-MO) – Sponsor of the funding ban proposal.
  • Speaker Mike Johnson (R-LA) – Recipient of Hawley’s letter; controls House agenda.
  • Planned Parenthood Federation of America – Targeted as a major Medicaid/Medicare recipient.
  • Secretary Robert F. Kennedy – Issued guidance on transgender youth care later blocked by courts.
  • Concerned Women for America – Conservative advocacy group cited for a study on Planned Parenthood’s gender-affirming services.

Funding Data and Reported Increases

Planned Parenthood received more than $1.5 billion in combined Medicaid and Medicare payments between 2019 and 2021. A study commissioned by Concerned Women for America reports a >40 % increase in gender-affirming visits, services, and care at Planned Parenthood and its affiliates during that period.

Official Statements & Responses

Hawley’s letter characterizes the potential funding as “unconscionable” and urges immediate House action to prevent the July 4 lapse of the existing funding bar. The House’s December vote reflects support for restricting gender-affirming care, while Senate leaders have publicly dismissed a national ban as premature. Federal courts have ruled that the HHS guidance restricting care exceeds statutory authority, effectively maintaining current access to gender-affirming services.

Criticism & Opposition

Senate colleagues have rejected the proposed prohibition, arguing that a federal ban would criminalize medical professionals and families. Judicial rulings against the HHS guidance underscore legal concerns about overreach. Critics also note that the 40 % increase claim relies on data from a partisan organization without independent verification.

Verbatim Quotes

  • “The ball is now in your court,” — Josh Hawley, Senator, Missouri
  • “If the House fails to act immediately as part of reconciliation, billions of Federal dollars will go to Planned Parenthood and other medical 'providers' for hormones, puberty blockers, and irreversible treatments for minor children.” — Josh Hawley
  • “Time is of the essence. As you well know, on July 4, the current federal bar on taxpayer payments to trans-treatment and abortion providers will expire,” — Josh Hawley
  • “We know what Planned Parenthood will use this money for. A new study by Concerned Women for America finds there has been a total increase of over 40 percent in ‘gender-affirming care,’ ‘gender-affirming visits,’ and ‘gender-affirming services’ at Planned Parenthood and its affiliates,” — Josh Hawley

Conflicting Reports & Gaps

The 40 % increase statistic originates from Concerned Women for America; the article provides no corroborating data from independent health agencies or Planned Parenthood itself. Additionally, the exact amount of federal spending that would be redirected to gender-affirming treatments after July 4 is not quantified.

What’s Next

The July 4 expiration of the existing funding bar creates a legislative deadline that Hawley hopes the House will meet. Pending House action, the issue may reappear in upcoming budget negotiations or be revisited through separate amendment proposals. Judicial scrutiny of any new funding restrictions is likely, given recent court interventions on related HHS guidance.